Editorial

Antibody-drug conjugates (ADCs) as precision targeted cancer therapies have started to deliver on their early promise as an innovative novel drug modality as demonstrated...

Antibodies serve an important function in the immune system by attaching to specific molecules, or antigens, on the surface of a foreign body, such...

The stated aim of my old school is to make pupils ‘real world-ready’. This is a project conceived as one of boundless ambition in...

As we plan ahead, for the upcoming digital World ADC Europe with much greater confidence, we were reflecting on what a year it has...

From liquid biopsies to precision medicine to immunology, the field of cancer treatment has experienced significant progress during the last decade. Although according to...

This week has brought welcome news to bladder cancer patients and their loved ones. Two drugs with great potential for combatting different types of...

With five antibody-drug conjugates (ADC) having received approval from the United States Food and Drug Administration (FDA) and other regulators around the world and...

With five approved and commercially available antibody-drug conjugates and nearly 100 in various stages of clinical development, it is exciting to see how the...

As we head into another election cycle, voters across the country can be assured that health care and the cost of prescription drugs will...

Oh, how far we’ve come! When we take a holistic look at the major milestones and obstacles in cancer care over the last half century,...